MARKET

PRGO

PRGO

Perrigo Co Plc
NYSE

Real-time Quotes | Nasdaq Last Sale

38.14
+0.56
+1.49%
After Hours: 38.14 0 0.00% 16:03 05/20 EDT
OPEN
37.98
PREV CLOSE
37.58
HIGH
38.45
LOW
37.38
VOLUME
1.72M
TURNOVER
0
52 WEEK HIGH
50.90
52 WEEK LOW
31.32
MARKET CAP
5.13B
P/E (TTM)
-37.7474
1D
5D
1M
3M
1Y
5Y
Danone ramps up baby formula shipments to U.S. after Abbott recall - Reuters
French food and beverage company Danone S.A. (OTCQX:DANOY) (OTCQX:GPDNF) has increased its shipments of infant formula to the U.S. from Europe as the country grapples with a baby formula shortage
Seekingalpha · 23h ago
PERRIGO TO PRESENT AT UPCOMING CONSUMER INVESTOR CONFERENCES
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO, Murray S. Kessler and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Credit Suisse HALO Investment Su...
PR Newswire · 1d ago
Biden invokes Defense Production Act to increase infant formula supply
reuters.com · 2d ago
TIMELINE-Baby formula crunch in U.S. forces scramble to boost supplies
reuters.com · 3d ago
U.S. Democrats unveil bill to address baby formula shortage
reuters.com · 3d ago
Enfamil maker Reckitt cranks up operations to put baby formula on U.S shelves
reuters.com · 4d ago
Reckitt Benckiser says it is working to boost baby formula output amid U.S. shortage
reuters.com · 4d ago
BRIEF-FDA Encourages Importation Of Safe Infant Formula And Other Flexibilities To Further Increase Availability
reuters.com · 4d ago
More
No Data
Learn about the latest financial forecast of PRGO. Analyze the recent business situations of Perrigo Co Plc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

16.67%Strong Buy
33.33%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average PRGO stock price target is 48.67 with a high estimate of 50.00 and a low estimate of 48.00.
High50.00
Average48.67
Low48.00
Current 38.14
EPS
Actual
Estimate
0.160.330.490.65
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 488
Institutional Holdings: 156.31M
% Owned: 116.18%
Shares Outstanding: 134.54M
TypeInstitutionsShares
Increased
124
13.99M
New
55
6.36M
Decreased
86
8.73M
Sold Out
52
4.50M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.90%
Pharmaceuticals & Medical Research
+1.64%
Key Executives
Non-Executive Chairman/Independent Director
Orlando Ashford
President/Chief Executive Officer/Director
Murray Kessler
Chief Financial Officer/Executive Vice President
Eduardo Bezerra
Chief Human Resource Officer/Executive Vice President
Robert Willis
Executive Vice President/Chief Information Officer
Thomas Farrington
Executive Vice President/General Counsel/Secretary
Todd Kingma
Executive Vice President
Svend Andersen
Executive Vice President
James Dillard
Executive Vice President
Ronald Janish
Executive Vice President
Grainne Quinn
Independent Director
Bradley Alford
Independent Director
Katherine Doyle
Independent Director
Adriana Karaboutis
Independent Director
Jeffrey Kindler
Independent Director
Erica Mann
Independent Director
Donal O'Connor
Independent Director
Geoffrey Parker
Independent Director
Theodore Samuels
No Data
No Data
About PRGO
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S), Mexico and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod and Firefly. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies and e-commerce channels.

Webull offers kinds of Perrigo Company PLC stock information, including NYSE:PRGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRGO stock methods without spending real money on the virtual paper trading platform.